Manufacturer record

Cian Healthcare Ltd. Kh.No. 248: regulatory record

Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

3 batches manufactured by Cian Healthcare Ltd. Kh.No. 248 (Uttarakhand) were declared Not of Standard Quality between March 2020 and June 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Records by type

3 records linked to Cian Healthcare Ltd. Kh.No. 248 in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
3Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, Mar 2020 to Jun 2026

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

3
NSQ batches since 2020
3
Products affected
Assay
Most common failure
Jun 2026
Latest alert

Flagged batches per year

2020 · 12025 · 12026 · 1

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
Tinycold-AF Chlorpheniramine Maleate & Phenylephrine Hydrochloride Syrup IP AI.25089Mfg 2025-07 · Exp 2027-06 The content of phanylephrine Hydrochloride in the sample is less (i.e. 66.80% of the labelled amount ) than IP limit (IP 90% to 110%)Labelling FDAL, MumbaiState lab Jun 2026
Calcium Carbonate & Vitamin D3 Tablets IP 1.25mg &500ml) CT24090Mfg 2024-04 · Exp 2026-03 The sample does not conform to the claim with respect to Assay Vitamin D3Assay DTL, JaipurState lab Jul 2025
Metoprolol Succinate Extended Release Tablets USP Metorol- XL 50 mg CT9167Mfg 2019-03 · Exp 2021-02 DissolutionDissolution RDTL ChandigarhCDSCO lab Mar 2020

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.